Home Categories Pharmaceutical intermediates N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
SDS-US
BD0046353

N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine , 98+% , 477600-73-0

CAS NO.：477600-73-0

Empirical Formula: C20H25N5

Molecular Weight: 335.45

MDL number: MFCD16877475

Pack Size Price Stock Quantity
100mg RMB648.00 In Stock
250mg RMB1000.00 In Stock
1g RMB2499.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 67-69℃
Density  1.205±0.06 g/cm3(Predicted)
storage temp.  under inert gas (nitrogen or Argon) at 2–8 °C
pka 13.36±0.50(Predicted)
InChI InChI=1S/C20H25N5/c1-15-9-11-25(12-16-6-4-3-5-7-16)13-18(15)24(2)20-17-8-10-21-19(17)22-14-23-20/h3-8,10,14-15,18H,9,11-13H2,1-2H3,(H,21,22,23)/t15-,18+/m1/s1
InChIKey UMWNXPTXDOVDFE-QAPCUYQASA-N
SMILES C1=NC(N(C)[C@@H]2[C@H](C)CCN(CC3=CC=CC=C3)C2)=C2C=CNC2=N1

Description and Uses

N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine is an important pharmaceutical intermediate used for the synthesis of tofacitinib. Tofacitinib is a Janus kinase (JAK) inhibitor drug used to treat rheumatoid arthritis and psoriatic arthritis.

RELATED PRODUCTS

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
1062580-52-2
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
477600-74-1
4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine
4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine
479633-63-1
N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
923036-30-0
2,6-Dichloro-7-deazapurine
2,6-Dichloro-7-deazapurine
90213-66-4